See the Informed Consent form for a complete list of risks and potential complications
Patients who have been on Wegovy or Zepbound through the program would face three options: Pay out of pocket at retail prices (currently $1,000-$1,300 per month) Discontinue the medication , which research suggests leads to significant weight regain Transition to an alternative covered treatment , such as bariatric surgery or other covered medications The STEP 1 extension study showed that patients who discontinued semaglutide regained approximately two-thirds of their lost weight within one year
All medications are compounded at licensed 503A pharmacies and shipped directly to your home, eliminating pharmacy markups and insurance processing delays
NMN (nicotinamide mononucleotide) serves as a direct precursor to NAD+, meaning the body converts it into NAD+ through natural metabolic pathways
We reviewed data from every major clinical trial published through January 2026 -- including the landmark STEP, SURMOUNT, and Retatrutide phase 2 programs -- to build this head-to-head comparison
Pei Z, Liu Y, Liu S, Jin W, Luo Y, Sun M, et al
